Jordi Aceitón
A5065230940- HIV/AIDS Research and Interventions
- COVID-19 Clinical Research Studies
- HIV-related health complications and treatments
- COVID-19 Impact on Reproduction
- SARS-CoV-2 and COVID-19 Research
- COVID-19 and healthcare impacts
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV Research and Treatment
- HIV, Drug Use, Sexual Risk
- Long-Term Effects of COVID-19
- Vaccine Coverage and Hesitancy
- COVID-19 Pandemic Impacts
- HIV/AIDS drug development and treatment
- Viral-associated cancers and disorders
- Colorectal and Anal Carcinomas
- Influenza Virus Research Studies
- COVID-19 epidemiological studies
- SARS-CoV-2 detection and testing
- Hepatitis C virus research
- Cervical Cancer and HPV Research
- COVID-19 and Mental Health
- Migration, Health and Trauma
Government of Catalonia
2021-2024
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
2021-2024
Departament de Salut
2024
Universitat de Barcelona
2021
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
2021
Abstract Background The role of children in household transmission severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear. We describe the epidemiological and clinical characteristics with disease 2019 (COVID-19) Catalonia, Spain, investigate dynamics. Methods A prospective, observational, multicenter study was performed during summer school periods (1 July 2020–31 October 2020) to analyze features viral dynamics COVID-19 patients aged <16 years. pediatric index...
BackgroundFactors affecting outcomes of SARS-CoV-2 infection in people living with HIV are unclear. We assessed the factors associated diagnosis and severe among HIV.MethodsWe did a retrospective cohort study using data from PISCIS Catalonia (Spain) between March 1 Dec 15, 2020. linked integrated health-care, clinical, surveillance registries through Public Data Analysis for Health Research Innovation Program (PADRIS) to obtain on diagnosis, chronic comorbidities, as well clinical mortality...
Journal Article Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands Get access Andreu Bruguera, Bruguera Centre Epidemiological Studies STI HIV/AIDS (CEEISCAT), Department Health, Generalitat de Catalunya, Badalona, SpainInstitute for Health Science Research Germans Trias i Pujol (IGTP), SpainCIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain https://orcid.org/0000-0002-7524-0768 Search other works by this author on: Oxford...
Reports on the impact of some antiretrovirals against SARS-CoV-2 infection and disease severity are conflicting.We evaluated effect tenofovir as either alafenamide/emtricitabine (TAF/FTC) or disoproxil fumarate/emtricitabine (TDF/FTC) associated clinical outcomes among people living with HIV (PLWH).We conducted a propensity score-matched analysis in prospective PISCIS cohort PLWH (n = 14 978) Catalonia, Spain. We used adjusted Cox regression models to assess association between...
Effective antiretroviral therapy (ART) has substantially reduced acquired immunodeficiency syndrome (AIDS)-related deaths, shifting the focus to non-AIDS conditions in people living with human virus (HIV) (PLWH). We examined mortality trends and predictors of AIDS- Population HIV Cohort from Catalonia Balearic Islands (PISCIS) cohort PLWH 1998 2020. used a modified Coding Causes Death protocol, which been widely adopted by various cohorts classify causes. applied standardized rates (SMR)...
People living with HIV (PLWH) are prioritised for SARS-CoV-2 vaccination due to their vulnerability severe COVID-19. Therefore, the epidemiological surveillance of coverage and timely identification suboptimally vaccinated PLWH is vital. We assessed factors associated under-vaccination among in Catalonia, Spain. As 11.12.2021, 9945/14942 (66.6%) had received ≥1 dose a vaccine. Non-Spanish origin (adjusted odds ratio (aOR) 0.64, 95% CI 0.59−0.70), CD4 count 200−349 cells/μL (aOR 0.74,...
People living with HIV who are lost to follow-up have a greater risk of health deterioration, mortality, and community transmission.Our aim was analyse both how rates loss (LTFU) changed between 2006 2020 the COVID-19 pandemic affected these in PISCIS cohort study Catalonia Balearic Islands.We analysed socio-demographic clinical characteristics LTFU yearly adjusted odds ratios assess impact determinants on (the year COVID-19). We used latent class analysis categorize classes based their at...
Coronavirus disease 2019 (COVID-19) disproportionately affects migrants and ethnic minorities, including those with human immunodeficiency virus (HIV). Comprehensive studies are needed to understand the impact risk factors. Using data from PISCIS cohort of people HIV (PWH) in Catalonia, Spain, we investigated COVID-19 outcomes vaccination coverage. Among 10 640 PWH compared non-migrants assessing rates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing, diagnosis,...
Introduction SARS-CoV-2 seroprevalence studies are currently being recommended and implemented in many countries. Forming part of the COVID-19 monitoring evaluation plan Catalan Government Health Department, our network aims to initiate a primary healthcare sentinel system as surrogate exposure Barcelona Metropolitan Area. Methods analysis The seroCAP is serial cross-sectional study, which will be performed Area estimate antibodies against SARS-CoV-2. From February 2021 March 2022, detection...
Objectives People with HIV (PWH) have a higher cardiovascular risk than the general population. It remains unclear, however, whether of disease (CVD) is in late presenters (LP; CD4 ≤ 350 cells/μL at diagnosis) compared to PWH diagnosed early. We aimed assess rates incident events (CVEs) following ART initiation among LP non-LP. Methods From prospective, multicentre PISCIS cohort, we included all adult people initiating antiretroviral therapy (ART) between 2005 and 2019 without prior CVE....
People with HIV (PWH) may be more susceptible to SARS-CoV-2 infection and worse clinical outcomes. We investigated the disparity in vaccination coverage between PWH those without (PWoH) Catalonia, Spain, assessing primary monovalent booster from December 2021 July 2022. The vaccines administered were BNT162, ChAdOx1-S, mRNA-127, Ad26.COV2.S. Using a 1:10 ratio of PWoH based on sex, age, socioeconomic deprivation, analysis included 201,630 individuals (183,300 18,330 PWH). Despite higher...
Background: Late HIV diagnosis is associated with poorer outcomes. However, determinants of long-term mortality and factors influencing immune recovery within the first years after antiretroviral treatment (ART) initiation are poorly defined. Methods: Observational, prospective, multicentre cohort study using data from PISCIS people living in Catalonia, Spain. We included all adults initiating ART between 2005 2019 surviving two years. The primary outcome was all-cause according to two-year...
Background: Late HIV diagnosis (CD4 ≤350 cells/µL) is associated with increased risks of AIDS and non-AIDS comorbidities, but its impact on cardiovascular events (CVE) remains unclear. Methods: From the prospective, multicentre PISCIS cohort, we included all adult people living (PLWH) initiating antiretroviral therapy (ART) between 2005-2019 without prior CVE. Additional data were extracted from public health registries. The primary outcome was incidence first CVE (ischemic heart disease,...